Bristol-Myers Squibb Reports First Quarter Financial Results

Go back to Bristol-Myers Squibb Reports First Quarter Financial Results

Bristol-Myers Squibb Co. (BMY) PT Raised to $53 at Deutsche Bank

April 27, 2018 9:19 AM EDT

Deutsche Bank raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $53.00 (from $52.00) while maintaining a Hold rating.

... More

Bristol-Myers Squibb (BMY) Tops Q1 EPS by 9c; Raises Outlook

April 26, 2018 7:01 AM EDT

Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $0.94, $0.09 better than the analyst estimate of $0.85. Revenue for the quarter came in at $5.2 billion versus the consensus estimate of $5.24 billion.

GUIDANCE:

Bristol-Myers Squibb sees FY2018 EPS of $3.35-$3.45, versus the consensus of... More